A Two-way Crossover Study Of The Effect Of Food On The Pharmacokinetics Of Pazopanib In Cancer Patients
Status:
Completed
Trial end date:
2009-06-19
Target enrollment:
Participant gender:
Summary
This is two-part study (Part I/Part II). Part I is designed to determine the effect of a low
and high fat meal on the pharmacokinetics of single dose pazopanib (GW572016). Part II is
designed to allow patients continued access to study drug in a multiple dosing regimen.
Patients who are receiving clinical benefit on that regimen will go into the long term
rollover study VEG105430 provided they are stable for 8 weeks.